臨床リスク分類ソリューションの世界市場2020-2026:製品別(スコアカード&視覚化ツール、ダッシュボード分析ソリューション、リスクレポートソリューション)、展開別、エンドユーザー別、地域別

◆英語タイトル:Global Clinical Risk Grouping Solutions Market Size study, by Product (Scorecards & Visualization Tools, Dashboard Analytics Solutions and Risk Reporting Solutions), by Deployment (Private Cloud, Public Cloud and Hybrid Cloud), by End-User (Hospitals, Payers, Ambulatory Care Services and Others), and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月25日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、臨床リスク分類ソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品別(スコアカード&視覚化ツール、ダッシュボード分析ソリューション、リスクレポートソリューション)分析、展開別分析、エンドユーザー別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・臨床リスク分類ソリューションの世界市場:製品別(スコアカード&視覚化ツール、ダッシュボード分析ソリューション、リスクレポートソリューション)
・臨床リスク分類ソリューションの世界市場:展開別
・臨床リスク分類ソリューションの世界市場:エンドユーザー別
・臨床リスク分類ソリューションの世界市場:地域別
・競争状況
【レポートの概要】

Global Clinical Risk Grouping Solutions Market is valued approximately at USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Clinical Risk Category (CRG) approach is a population classification system that uses outpatient and inpatient diagnostic and treatment codes, clinical health status, and prescription data to assign each person to a single, severity-adjusted category. Social risk category is a professional evidence-based categorical rating system that uses statistical data to identify adults and children with chronic health problems. Rising consumer awareness regarding risk management, increasing utilization of big data, and high demand for the reduction of rising healthcare expenditures are the few factors responsible for high CAGR of the market over the forecast period. Moreover, increasing physician burnout due to documentation needs along with increasing focus on AI and machine learning are few factors likely to create lucrative growth opportunities to the growth of market in the forecasting years. However, a lack of infrastructure for supporting the clinical risk grouping solutions technology is one of the major factors anticipated to limit the growth of global Clinical Risk Grouping Solutions market during the forecast period.
The regional analysis of CNC Milling Machines market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America holds the biggest share of the regional market for therapeutic risk classification solutions. Increasing policy policies on public health reduction, a supportive regulatory environment, the involvement of large service vendors and the need to minimize patient care mistakes propel the North American market for clinical risk grouping solutions.

Major market player included in this report are:
3M Company
Cerner Corporation
Nuance Communications
Conduent Inc.
HBI Solutions, Inc.
4S Information Systems Ltd.
Johns Hopkins University
PeraHealth, Inc.
Health Catalyst Inc.
Evolent Health
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Scorecards & Visualization Tools
Dashboard Analytics Solutions
Risk Reporting Solutions
By Deployment:
Private Cloud
Public Cloud
Hybrid Cloud
By End-User:
Hospitals
Payers
Ambulatory Care Centres
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the CNC Milling Machines Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Global Clinical Risk Grouping Solutions Market, by Region, 2018-2026 (USD Billion)
1.2.2. Global Clinical Risk Grouping Solutions Market, by Product, 2018-2026 (USD Billion)
1.2.3. Global Clinical Risk Grouping Solutions Market, by Deployment, 2018-2026 (USD Billion)
1.2.4. Global Clinical Risk Grouping Solutions Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Risk Grouping Solutions Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Risk Grouping Solutions Market Dynamics
3.1. Global Clinical Risk Grouping Solutions Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Clinical Risk Grouping Solutions Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Clinical Risk Grouping Solutions Market, by Product
5.1. Market Snapshot
5.2. Global Clinical Risk Grouping Solutions Market by Product, Performance – Potential Analysis
5.3. Global Clinical Risk Grouping Solutions Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4. Global Clinical Risk Grouping Solutions Market, Sub Segment Analysis
5.4.1. Scorecards & Visualization Tools
5.4.2. Dashboard Analytics Solutions
5.4.3. Risk Reporting Solutions
Chapter 6. Global Clinical Risk Grouping Solutions Market, by Deployment
6.1. Market Snapshot
6.2. Global Clinical Risk Grouping Solutions Market by Deployment, Performance – Potential Analysis
6.3. Global Clinical Risk Grouping Solutions Market Estimates & Forecasts by Deployment 2016-2026 (USD Billion)
6.4. Global Clinical Risk Grouping Solutions Market, Sub Segment Analysis
6.4.1. Private Cloud
6.4.2. Public Cloud
6.4.3. Hybrid Cloud
Chapter 7. Global Clinical Risk Grouping Solutions Market, by End-User
7.1. Market Snapshot
7.2. Global Clinical Risk Grouping Solutions Market by End-User, Performance – Potential Analysis
7.3. Global Clinical Risk Grouping Solutions Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
7.4. Global Clinical Risk Grouping Solutions Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Payers
7.4.3. Ambulatory Care Centres
7.4.4. Others
Chapter 8. Global Clinical Risk Grouping Solutions Market, Regional Analysis
8.1. Global Clinical Risk Grouping Solutions Market, Regional Market Snapshot
8.2. North America Global Clinical Risk Grouping Solutions Market
8.2.1. U.S. Global Clinical Risk Grouping Solutions Market
8.2.1.1. Product breakdown estimates & forecasts, 2016-2026
8.2.1.2. Deployment breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Global Clinical Risk Grouping Solutions Market
8.3. Europe Global Clinical Risk Grouping Solutions Market Snapshot
8.3.1. U.K. Global Clinical Risk Grouping Solutions Market
8.3.2. Germany Global Clinical Risk Grouping Solutions Market
8.3.3. Rest of Europe Global Clinical Risk Grouping Solutions Market
8.4. Asia-Pacific Global Clinical Risk Grouping Solutions Market Snapshot
8.4.1. China Global Clinical Risk Grouping Solutions Market
8.4.2. India Global Clinical Risk Grouping Solutions Market
8.4.3. Japan Global Clinical Risk Grouping Solutions Market
8.4.4. Rest of Asia Pacific Global Clinical Risk Grouping Solutions Market
8.5. Latin America Global Clinical Risk Grouping Solutions Market Snapshot
8.5.1. Brazil Global Clinical Risk Grouping Solutions Market
8.5.2. Mexico Global Clinical Risk Grouping Solutions Market
8.6. Rest of The World Global Clinical Risk Grouping Solutions Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. 3M Company
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Cerner Corporation
9.2.3. Nuance Communications
9.2.4. Conduent Inc.
9.2.5. HBI Solutions, Inc.
9.2.6. 4S Information Systems Ltd.
9.2.7. Johns Hopkins University
9.2.8. Perahealth, Inc.
9.2.9. Health Catalyst Inc.
9.2.10. Evolent Health
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET
TABLE 3. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
TABLE 8. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY DEPLOYMENT 2016-2026 (USD BILLION)
TABLE 9. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 10. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. U.S. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. U.S. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. U.S. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. CANADA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. CANADA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. CANADA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. UK GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. UK GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. UK GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. GERMANY GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. GERMANY GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. GERMANY GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. ROE GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. ROE GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. ROE GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. CHINA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. CHINA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. CHINA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. INDIA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. INDIA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. INDIA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. JAPAN GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. JAPAN GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. JAPAN GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROAPAC GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROAPAC GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROAPAC GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. BRAZIL GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. BRAZIL GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. BRAZIL GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. MEXICO GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 59. MEXICO GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. MEXICO GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 61. ROLA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 62. ROLA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. ROLA GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 64. ROW GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 65. ROW GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 66. ROW GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床リスク分類ソリューションの世界市場2020-2026:製品別(スコアカード&視覚化ツール、ダッシュボード分析ソリューション、リスクレポートソリューション)、展開別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆